Get Premium to unlock powerful stock data
LTS:0QIU (Denmark)  
Novo Nordisk A/S logo

Novo Nordisk A/S

kr 790.50 (+1.64%) Jul 4
P/E:
37.00
P/B:
27.19
Market Cap:
kr 1.80T ($ 249.30B)
Enterprise V:
kr 1.81T ($ 250.04B)
Volume:
1.37M
Avg Vol (2M):
848.31K
Also Trade In:
Volume:
1.37M
Market Cap kr:
1.80T
Market Cap $:
249.30B
PE Ratio:
37.00
Avg Vol (2-Month):
848.31K
Enterprise Value kr:
1.81T
Enterprise Value $:
250.04B
PB Ratio:
27.19
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Financials (Next Earnings Date:2022-07-07 Est.)

LTS:0QIU's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 149,027
EPS (TTM) (kr) 21.51
Beta 0.21
Volatility % 25.49
14-Day RSI 57.83
14-Day ATR (kr) 20.541477
20-Day SMA (kr) 775.97
12-1 Month Momentum % 43.96
52-Week Range (kr) 526.88966 - 831.6
Shares Outstanding (Mil) 2,264.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novo Nordisk A/S Filings

Document Form Filing Date
No Filing Data